Literature DB >> 32426310

Are Children Most of the Submerged Part of SARS-CoV-2 Iceberg?

Stefano Passanisi1, Fortunato Lombardo1, Giuseppina Salzano1, Giovanni Battista Pajno1.   

Abstract

Entities:  

Keywords:  COVID-19; Italy; children; coronavirus; outbreak; pandemic; transmission

Year:  2020        PMID: 32426310      PMCID: PMC7204432          DOI: 10.3389/fped.2020.00213

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


× No keyword cloud information.

Introduction

Since the end of 2019, a novel coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been developing in Wuhan, Hubei Province, China (1). In very few months it has spread all over the world and the World Health Organization on March 11, 2020 declared COVID-19 a pandemic. Italy is currently one of the most affected countries in Europe. At the time of this publication, 120,290 cases of SARS-CoV-2 infection have been detected. Median age of infected patients is 62 years. Interestingly, only 1.5% of patients diagnosed with SARS-CoV-2 are aged 0–18 years. Thus far, among the 14,381 subjects who died with SARS-CoV-2 in Italy, there was only one child (2). These data are in concordance with those reported from other European countries and a recent review of 72,314 COVID-19 patients by the Chinese Center for Disease Control and Prevention that revealed that there were <1% of pediatric cases. Furthermore, among children younger than 10 years of age no deaths were reported (3). Even during the outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV) and middle-east respiratory syndrome coronavirus (MERS-CoV) the rate of infected children was quite low (5–7% and 2–3%, respectively) (4, 5).

SARS-CoV-2 Infection in Children

The most common symptoms in children with confirmed SARS-CoV-2 are fever, dry cough, pharyngeal erythema, and fatigue (6). Recently, Dong et al. described a cohort of 2,143 Chinese children with suspected or confirmed COVID-19. The authors reported that among symptomatic children, only 5% had dyspnoea or hypoxemia and 0.6% presented acute respiratory distress syndrome or multiorgan failure (7). Early laboratory markers that are typically associated to SARS-CoV-2 infection in adults such as lymphopenia, increased liver enzymes, anemia, increased inflammatory markers, are very rare in children (8). The reasons why children appear to be less affected and if infected develop milder clinical pictures due to COVID-19 are still uncertain. Several hypothesis have been put forward. Children may have a more effective response against SARS-CoV-2 as their immune system may be strengthened by the recurrence of several viral infections toward which they tend in the first years of life. In addition, adults seem to have a more vigorous immune response that may lead to “cytokine storm” which will further deteriorate lung injury (9). This theory is supported by the rare increase of inflammatory markers in children with confirmed COVID-19, as reported above. Another interesting hypothesis is related to angiotensin-converting enzyme 2 (ACE2). This enzyme is widely expressed in organs, including lungs in which it seems to act in a protective manner especially against severe respiratory virus disease (10). The extracellular domain of ACE2 has been demonstrated to be the functional receptor for the spike protein of SARS-CoV, and recently, of the SARS-CoV-2 (11). Experiments in rats show that the pulmonary renin angiotensin system undergoes an age-dependent imbalance toward a more pronounced inflammation and more severe lung injury (12). In fact, ACE2 expression was seen to significantly decrease with increasing age in rat lung models, with old male rats having the lowest levels (13). Therefore, a higher concentration of ACE2 in lung pneumocytes in children could explain the rarity of severe clinical manifestations due to SARS-CoV-2 infection. Other suggested reasons that may contribute include lack of smoking, less exposure to air pollution and fewer underlying chronic conditions in children rather than adults (14). However, further studies are awaited to better investigate the underlying mechanisms that lead to milder disease presentation in the pediatric population.

Discussion

Although more than a million people have already had a confirmed diagnosis of SARS-CoV-2 worldwide, there is a strong impression that the true prevalence of SARS-CoV-2 infection is much higher. For instance, one study suggested that 86% of all early SARS-CoV-2 infections in China remained undiagnosed (15). Pharyngeal and nasal swabs, which represent the most used diagnostic investigations, are mostly reserved to those individuals who present severe illness. In addition, the sensitivity of these tests is not yet known, but numerous false negatives may occur, since the virus may have translocated from the upper to the lower airways. Therefore, people with confirmed diagnosis may only be the tip of the iceberg of SARS-CoV-2 pandemic. The majority of infected children do not undergo diagnostic investigations for COVID-19 as they are asymptomatic or mildly symptomatic. Available data indicate that children who become infected with SARS-CoV-2 may have more upper respiratory tract rather than lower respiratory tract involvement (7). This may explain the low rate of infected pediatric patients reported in epidemiological studies. Fecal shedding persists in the stool for several weeks after diagnosis (16). Extended shedding in nasal secretions and stool may have remarkable implications for community spread in kindergartens, schools, and at home (17). Therefore, the role of children in community-based viral transmission should be carefully investigated to understand how much it can actually affect public health. In the meantime, several countries have issued strict governmental decrees prohibiting movement in public places except for justifiable work reasons, basic necessities (i.e., food shopping), and health emergencies. School closures were among the first measures which had been adopted. According to UNESCO monitoring, over 160 countries have implemented nationwide closures, impacting over 87% of world's student population. Together these hard interventions seem to give encouraging results (18): reducing the contagion among the pediatric population could be a first step to curb the spread of COVID-19.

Author Contributions

SP drafted and wrote the paper. GS and FL contributed to the discussion. GP reviewed and approved the paper.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  14 in total

1.  Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

Authors:  Daniel Batlle; Jan Wysocki; Karla Satchell
Journal:  Clin Sci (Lond)       Date:  2020-03-13       Impact factor: 6.124

2.  COVID-19 in Children: Initial Characterization of the Pediatric Disease.

Authors:  Andrea T Cruz; Steven L Zeichner
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

3.  Age-Dependent Changes in the Pulmonary Renin-Angiotensin System Are Associated With Severity of Lung Injury in a Model of Acute Lung Injury in Rats.

Authors:  Laura R A Schouten; Hendrik J F Helmerhorst; Gerry T M Wagenaar; Tom Haltenhof; René Lutter; Joris J T H Roelofs; Job B M van Woensel; Anton H L C van Kaam; Albert P Bos; Marcus J Schultz; Thomas Walther; Roelie M Wösten-van Asperen
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

4.  Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015.

Authors:  F S Alhamlan; M S Majumder; J S Brownstein; J Hawkins; H M Al-Abdely; A Alzahrani; D A Obaid; M N Al-Ahdal; A BinSaeed
Journal:  BMJ Open       Date:  2017-01-12       Impact factor: 2.692

5.  Age- and gender-related difference of ACE2 expression in rat lung.

Authors:  Xudong Xie; Xie Xudong; Junzhu Chen; Chen Junzhu; Xingxiang Wang; Wang Xingxiang; Furong Zhang; Zhang Furong; Yanrong Liu; Liu Yanrong
Journal:  Life Sci       Date:  2005-11-21       Impact factor: 5.037

6.  Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus.

Authors:  Hongjing Gu; Zhengde Xie; Tieling Li; Shaogeng Zhang; Chengcai Lai; Ping Zhu; Keyu Wang; Lina Han; Yueqiang Duan; Zhongpeng Zhao; Xiaolan Yang; Li Xing; Peirui Zhang; Zhouhai Wang; Ruisheng Li; Jane J Yu; Xiliang Wang; Penghui Yang
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

7.  Are children less susceptible to COVID-19?

Authors:  Ping-Ing Lee; Ya-Li Hu; Po-Yen Chen; Yhu-Chering Huang; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2020-02-25       Impact factor: 4.399

8.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Authors:  David S Hui; Esam I Azhar; Tariq A Madani; Francine Ntoumi; Richard Kock; Osman Dar; Giuseppe Ippolito; Timothy D Mchugh; Ziad A Memish; Christian Drosten; Alimuddin Zumla; Eskild Petersen
Journal:  Int J Infect Dis       Date:  2020-01-14       Impact factor: 3.623

9.  A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features.

Authors:  Cai Jiehao; Xu Jin; Lin Daojiong; Yang Zhi; Xu Lei; Qu Zhenghai; Zhang Yuehua; Zhang Hua; Jia Ran; Liu Pengcheng; Wang Xiangshi; Ge Yanling; Xia Aimei; Tian He; Chang Hailing; Wang Chuning; Li Jingjing; Wang Jianshe; Zeng Mei
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  6 in total

Review 1.  SARS-CoV-2 Infection and the Newborn.

Authors:  Fahri Ovalı
Journal:  Front Pediatr       Date:  2020-05-22       Impact factor: 3.418

Review 2.  SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings.

Authors:  Phoebe C M Williams; Annaleise R Howard-Jones; Peter Hsu; Pamela Palasanthiran; Paul E Gray; Brendan J McMullan; Philip N Britton; Adam W Bartlett
Journal:  Pathology       Date:  2020-08-19       Impact factor: 5.306

Review 3.  Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease.

Authors:  Valeria Dipasquale; Stefano Passanisi; Ugo Cucinotta; Antonio Cascio; Claudio Romano
Journal:  Ital J Pediatr       Date:  2021-03-24       Impact factor: 2.638

4.  Changes in Eating Habits and Sedentary Behavior During the COVID-19 Pandemic in Adolescents With Chronic Conditions.

Authors:  Bruna Caruso Mazzolani; Fabiana Infante Smaira; Camilla Astley; Amanda Yuri Iraha; Ana Jessica Pinto; Isabela Gouveia Marques; Milla Cordeiro Amarante; Nathalia Saffioti Rezende; Sofia Mendes Sieczkowska; Tathiane Christine Franco; Luana Cristina do Amaral Miranda; Lívia Lindoso; Alberto Carame Helito; Jane Oba; Ligia Bruni Queiroz; Rosa Maria R Pereira; Hamilton Roschel; Clovis Artur Silva; Bruno Gualano
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

5.  Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic.

Authors:  Concetta Mastromauro; Annalisa Blasetti; Marina Primavera; Lucio Ceglie; Angelika Mohn; Francesco Chiarelli; Cosimo Giannini
Journal:  Ital J Pediatr       Date:  2022-02-09       Impact factor: 2.638

6.  "CoVidentary": An online exercise training program to reduce sedentary behaviours in children with type 1 diabetes during the COVID-19 pandemic.

Authors:  Valeria Calcaterra; Dario Iafusco; Vittoria Carnevale Pellino; Chiara Mameli; Gianluca Tornese; Antonietta Chianese; Crescenzo Cascella; Maddalena Macedoni; Francesca Redaelli; Gianvincenzo Zuccotti; Matteo Vandoni
Journal:  J Clin Transl Endocrinol       Date:  2021-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.